Improving care transitions for adults with congenital heart disease
Improving transitions of care for adults with congenital heart disease
This study is testing a new mobile app designed to help adults with congenital heart disease better manage their health as they move from pediatric to adult care, making it easier for them to understand their condition and take charge of their treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10908570 on NIH RePORTER |
What this research studies
This research focuses on enhancing the transition of care for adults with congenital heart disease (ACHD) by developing a mobile app-based intervention. The app aims to empower patients by improving their knowledge and self-management skills, which are crucial during the transition from pediatric to adult healthcare. By incorporating behavior change theories into the app's design, the research seeks to create a scalable solution that can help patients engage more effectively in their own care. The project addresses the significant gap in specialist care that many ACHD patients experience, particularly during critical transition periods.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have congenital heart disease and are transitioning from pediatric to adult healthcare.
Not a fit: Patients who do not have congenital heart disease or those who are not transitioning to adult care may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and better management of congenital heart disease for adults.
How similar studies have performed: Other research has shown success with mobile health interventions in chronic disease management, indicating potential for this approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Agarwal, Anushree — University of California, San Francisco
- Study coordinator: Agarwal, Anushree
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.